Kura Oncology

PriceKura Oncology

KURA

Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company’s pipeline consists of small molecule drug candidates targeting cancer signaling pathways.

Historical stock price chart and annual return over the past years

-29%

5 years

% Total

KURA
-7%

5 years

Annual Return

KURA